Skip to main content

Advertisement

SpringerLink
Log in

Asbestos-Related Diseases and Its Impact on Health: An Updated Review Article

  • REVIEW
  • Published:
Current Pulmonology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Asbestos is a naturally occurring mineral with a wide range of application in various industries. It has been linked with respiratory and non-respiratory illnesses. We aim to discuss the various pathologies caused due to asbestos exposure with succinct coverage of all areas of asbestosis study.

Recent Findings

Asbestos continues to be used in many industries. Currently, cosmetic products contaminated by asbestos raise the problem of continuous exposure to a proven carcinogen. Various conditions like effusions, plaques, pneumoconiosis, mesothelioma, and lung cancer are associated with it. The development of respiratory problems has a dose–response relationship with asbestos. Currently, no pharmacological therapy has demonstrated efficacy in the treatment of asbestosis.

Summary

The diagnosis of asbestos-related illnesses should have a clear history of exposure to the mineral and suggestive clinical and imaging findings. As the therapy of asbestos-related illnesses is not curative, the main aim should be to limit asbestos exposure. Besides, alternative materials should be promoted instead of asbestos to reduce its usage further.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Gulati M, Redlich CA. Asbestosis and environmental causes of usual interstitial pneumonia. Curr Opin Pulm Med. 2015;21(2):193–200. https://doi.org/10.1097/MCP.0000000000000144.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. •• Types of asbestos - chrysotile, actinolite, tremolite & more. https://www.asbestos.com/asbestos/types/. Accessed 8 Dec 2022. Papers provide important information on types of fibers/statistics and a regulation of asbestos seen in USA.

  3. • Asbestos Statistics and Information | U.S. Geological Survey. https://www.usgs.gov/centers/national-minerals-information-center/asbestos-statistics-and-information. Accessed 9 Dec 2022. Papers provide important information on types of fibers/statistics and a regulation of asbestos seen in USA.

  4. • Kamp DW. Asbestos-induced lung diseases: an update. Transl Res. 2009;153(4):143. https://doi.org/10.1016/J.TRSL.2009.01.004. Covers the mechanisms/pathogenesis of asbestos affecting humans.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. O’Reilly KMA, McLaughlin AM, Beckett WS, Sime PJ. Asbestos-related lung disease. Am Fam Physician. 2007;75(5):683–8. https://www.aafp.org/pubs/afp/issues/2007/0301/p683.html. Accessed 29 Apr 2023.

  6. Stayner L, Welch LS, Lemen R. The worldwide pandemic of asbestos-related diseases. Annu Rev Public Health. 2013;34:205–16. https://doi.org/10.1146/ANNUREV-PUBLHEALTH-031811-124704.

    Article  PubMed  Google Scholar 

  7. Bird T, Steffen JE, Tran TH, Egilman DS. A review of the talc industry’s influence on federal regulation and scientific standards for asbestos in talc. New Solut. 2021;31(2):152. https://doi.org/10.1177/1048291121996645.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Gordon RE, Fitzgerald S, Millette J. Asbestos in commercial cosmetic talcum powder as a cause of mesothelioma in women. Int J Occup Environ Health. 2014;20(4):318. https://doi.org/10.1179/2049396714Y.0000000081.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Diandini R, Takahashi K, Park EK, et al. Potential years of life lost (PYLL) caused by asbestos-related diseases in the world. Am J Ind Med. 2013;56(9):993–1000. https://doi.org/10.1002/AJIM.22206.

    Article  Google Scholar 

  10. Furuya S, Chimed-Ochir O, Takahashi K, David A, Takala J. Global asbestos disaster. Int J Environ Res Public Health. 2018. https://doi.org/10.3390/IJERPH15051000.

    Article  PubMed  PubMed Central  Google Scholar 

  11. • Nicholson WJ, Perkel G, Selikoff IJ. Occupational exposure to asbestos: population at risk and projected mortality–1980-2030. Am J Ind Med. 1982;3(3):259–311. https://doi.org/10.1002/AJIM.4700030305. Provide trajectory of asthma in isa and related mortality.

    Article  CAS  PubMed  Google Scholar 

  12. LaDou J. The asbestos cancer epidemic. Environ Health Perspect. 2004;112(3):285. https://doi.org/10.1289/EHP.6704.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Types of asbestos fibers | Classifying asbestos | Asbestos network. https://www.asbestosnetwork.com/what-is-asbestos/types-of-fibers/. Accessed 9 Dec 2022.

  14. Asbestos Statistics and Information | U.S. Geological Survey. https://www.usgs.gov/centers/national-minerals-information-center/asbestos-statistics-and-information. Accessed 29 Apr 2023.

  15. Document Display | NEPIS | US EPA. National Service Center for Environmental Publications (NSCEP).

  16. Lorber M, Gibb H, Grant L, Pinto J, Pleil J, Cleverly D. Assessment of inhalation exposures and potential health risks to the general population that resulted from the collapse of the World Trade Center towers. Risk Anal. 2007;27(5):1203–21. https://doi.org/10.1111/J.1539-6924.2007.00956.X.

    Article  PubMed  Google Scholar 

  17. • Asbestos toxicity: what are U.S. standards and regulations for asbestos levels? | Environmental Medicine | ATSDR. Papers provide important information on types of fibers/ statistics and a regulation of asbestos seen in USA.

  18. on the protection of workers from the risks related to exposure to asbestos at work (codified version) (Text with EEA relevance). Published online 2009.

  19. Lemen RA, Landrigan PJ. Toward an asbestos ban in the United States. Int J Environ Res Public Health. 2017. https://doi.org/10.3390/ijerph14111302.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Baur X, Woitowitz HJ, Budnik LT, et al. Asbestos, asbestosis, and cancer: the Helsinki criteria for diagnosis and attribution. Critical need for revision of the 2014 update. Am J Ind Med. 2017;60(5):411–21. https://doi.org/10.1002/AJIM.22709.

    Article  PubMed  Google Scholar 

  21. SH P, DM K, BH K, YK K, JE K. Risk assessment of gastric cancer associated with asbestosis: a case report. Ann Occup Environ Med. 2015. https://doi.org/10.1186/S40557-015-0061-4.

    Article  Google Scholar 

  22. Park S, Park J, Lee E, et al. Ovarian cancer in a former asbestos textile factory worker: a case report. Ann Occup Environ Med. 2018. https://doi.org/10.1186/S40557-018-0277-1.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Harris EJA, Musk A, de Klerk N, Reid A, Franklin P, Brims FJH. Diagnosis of asbestos-related lung diseases. Expert Rev Respir Med. 2019;13(3):241–9. https://doi.org/10.1080/17476348.2019.1568875.

    Article  CAS  PubMed  Google Scholar 

  24. Lazarus AA, Philip A. Asbestosis. Dis Mon. 2011;57(1):14–26. https://doi.org/10.1016/J.DISAMONTH.2010.11.004.

    Article  PubMed  Google Scholar 

  25. Bayram M, Bakan ND. Environmental exposure to asbestos: from geology to mesothelioma. Curr Opin Pulm Med. 2014;20(3):301–7. https://doi.org/10.1097/MCP.0000000000000053.

    Article  CAS  PubMed  Google Scholar 

  26. Niklinski J, Niklinska W, Chyczewska E, et al. The epidemiology of asbestos-related diseases. Lung Cancer. 2004. https://doi.org/10.1016/J.LUNGCAN.2004.04.008.

    Article  PubMed  Google Scholar 

  27. Wagner GR. Asbestosis and silicosis. Lancet. 1997;349(9061):1311–5. https://doi.org/10.1016/S0140-6736(96)07336-9.

    Article  CAS  PubMed  Google Scholar 

  28. Nielsen LS, Bælum J, Rasmussen J, et al. Occupational asbestos exposure and lung cancer–a systematic review of the literature. Arch Environ Occup Health. 2014;69(4):191–206. https://doi.org/10.1080/19338244.2013.863752.

    Article  CAS  PubMed  Google Scholar 

  29. Magnani C, Terracini B, Ivaldi C, et al. A cohort study on mortality among wives of workers in the asbestos cement industry in Casale Monferrato, Italy. Br J Ind Med. 1993;50(9):779–84. https://doi.org/10.1136/OEM.50.9.779.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Ferrante D, Bertolotti M, Todesco A, Mirabelli D, Terracini B, Magnani C. Cancer mortality and incidence of mesothelioma in a cohort of wives of asbestos workers in Casale Monferrato, Italy. Environ Health Perspect. 2007;115(10):1401. https://doi.org/10.1289/EHP.10195.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Lippmann M. Effects of fiber characteristics on lung deposition, retention, and disease. Environ Health Perspect. 1990;88:311. https://doi.org/10.1289/EHP.9088311.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Brody AR, Hill LH, Adkins B, O’Connor RW. Chrysotile asbestos inhalation in rats: deposition pattern and reaction of alveolar epithelium and pulmonary macrophages. Am Rev Respir Dis. 1981;123(6):670–9. https://doi.org/10.1164/ARRD.1981.123.6.670.

    Article  CAS  PubMed  Google Scholar 

  33. Chang LY, Overby LH, Brody AR, Crapo JD. Progressive lung cell reactions and extracellular matrix production after a brief exposure to asbestos. Am J Pathol. 1988;131(1):156.

    CAS  PubMed  PubMed Central  Google Scholar 

  34. • Kamp DW, Weitzman SA. The molecular basis of asbestos induced lung injury. Thorax. 1999;54(7):638–52. https://doi.org/10.1136/THX.54.7.638. Covers the mechanisms/pathogenesis of asbestos affecting humans.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Mossman BT, Churg A. Mechanisms in the pathogenesis of asbestosis and silicosis. Am J Respir Crit Care Med. 1998;157(5 Pt 1):1666–80. https://doi.org/10.1164/AJRCCM.157.5.9707141.

    Article  CAS  PubMed  Google Scholar 

  36. Mossman BT, Bignon J, Corn M, Seaton A, Gee JBL. Asbestos: scientific developments and implications for public policy. Science. 1990;247(4940):294–301. https://doi.org/10.1126/SCIENCE.2153315.

    Article  CAS  PubMed  Google Scholar 

  37. Mossman BT, Kamp DW, Weitzman SA. Mechanisms of carcinogenesis and clinical features of asbestos-associated cancers. Cancer Invest. 1996;14(5):466–80. https://doi.org/10.3109/07357909609018904.

    Article  CAS  PubMed  Google Scholar 

  38. Rom WN, Travis WD, Brody AR. Cellular and molecular basis of the asbestos-related diseases. Am Rev Respir Dis. 1991;143(2):408–22. https://doi.org/10.1164/AJRCCM/143.2.408.

    Article  CAS  PubMed  Google Scholar 

  39. Kamp DW, Graceffa P, Pryor WA, Weitzman SA. The role of free radicals in asbestos-induced diseases. Free Radic Biol Med. 1992;12(4):293–315. https://doi.org/10.1016/0891-5849(92)90117-Y.

    Article  CAS  PubMed  Google Scholar 

  40. • Sayan M, Mossman BT. The NLRP3 inflammasome in pathogenic particle and fibre-associated lung inflammation and diseases. Part Fibre Toxicol. 2016. https://doi.org/10.1186/S12989-016-0162-4. Covers the mechanisms/pathogenesis of asbestos affecting humans.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Hillegass JM, Miller JM, MacPherson MB, et al. Asbestos and erionite prime and activate the NLRP3 inflammasome that stimulates autocrine cytokine release in human mesothelial cells. Part Fibre Toxicol. 2013;10(1):39. https://doi.org/10.1186/1743-8977-10-39.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Berman DW, Crump KS. A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type. Crit Rev Toxicol. 2008;38(Suppl 1):49–73. https://doi.org/10.1080/10408440802273156.

    Article  CAS  PubMed  Google Scholar 

  43. Neri M, Ugolini D, Dianzani I, et al. Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases. Mutat Res Rev Mutat Res. 2008;659(1–2):126–36. https://doi.org/10.1016/J.MRREV.2008.02.002.

    Article  CAS  Google Scholar 

  44. Neri M, Taioli E, Filiberti R, et al. Metabolic genotypes as modulators of asbestos-related pleural malignant mesothelioma risk: a comparison of Finnish and Italian populations. Int J Hyg Environ Health. 2006;209(4):393–8. https://doi.org/10.1016/j.ijheh.2006.03.002.

    Article  CAS  PubMed  Google Scholar 

  45. Kukkonen MK, Hämäläinen S, Kaleva S, et al. Genetic susceptibility to asbestos-related fibrotic pleuropulmonary changes. Eur Respir J. 2011;38(3):672–8. https://doi.org/10.1183/09031936.00049810.

    Article  CAS  PubMed  Google Scholar 

  46. Zephaniah HS, Aremu SO. Asbestos: a silent potent killer. Eur J Environ Public Health. 2019;3(2):em0030. https://doi.org/10.29333/EJEPH/5906.

  47. Paris C, Thierry S, Brochard P, et al. Pleural plaques and asbestosis: dose- and time-response relationships based on HRCT data. Eur Respir J. 2009;34(1):72–9. https://doi.org/10.1183/09031936.00094008.

    Article  CAS  PubMed  Google Scholar 

  48. Mastrangelo G, Ballarin MN, Bellini E, et al. Asbestos exposure and benign asbestos diseases in 772 formerly exposed workers: dose-response relationships. Am J Ind Med. 2009;52(8):596–602. https://doi.org/10.1002/AJIM.20713.

    Article  CAS  PubMed  Google Scholar 

  49. Wolff H, Vehmas T, Oksa P, Rantanen J, Vainio H. Asbestos, asbestosis, and cancer, the Helsinki criteria for diagnosis and attribution 2014: recommendations. Scand J Work Environ Health. 2015;41(1):5–15. https://doi.org/10.5271/SJWEH.3462.

    Article  PubMed  Google Scholar 

  50. Lee YCG, Singh B, Pang SC, De Klerk NH, Hillman DR, Musk AW. Radiographic (ILO) readings predict arterial oxygen desaturation during exercise in subjects with asbestosis. Occup Environ Med. 2003;60(3):201–6. https://doi.org/10.1136/OEM.60.3.201.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Roggli VL, Gibbs AR, Attanoos R, et al. Pathology of asbestosis- an update of the diagnostic criteria: report of the Asbestosis Committee of the College of American Pathologists and Pulmonary Pathology Society. Arch Pathol Lab Med. 2010;134(3):462–80. https://doi.org/10.5858/134.3.462.

    Article  PubMed  Google Scholar 

  52. Weill H, Hughes JM, Churg AM. Changing trends in US mesothelioma incidence. Occup Environ Med. 2004;61(5):438–41. https://doi.org/10.1136/oem.2003.010165.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Marsh GM, Riordan AS, Keeton KA, Benson SM. Non-occupational exposure to asbestos and risk of pleural mesothelioma: review and meta-analysis. Occup Environ Med. 2017;74(11):838–46. https://doi.org/10.1136/OEMED-2017-104383.

    Article  PubMed  Google Scholar 

  54. Ramada Rodilla JM, Calvo Cerrada B, Serra Pujadas C, Delclos GL, Benavides FG. Fiber burden and asbestos-related diseases: an umbrella review. Gac Sanit. 2021. https://doi.org/10.1016/J.GACETA.2021.04.001.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Markowitz S. Asbestos-related lung cancer and malignant mesothelioma of the pleura: selected current issues. Semin Respir Crit Care Med. 2015;36(3):334–46. https://doi.org/10.1055/S-0035-1549449.

    Article  PubMed  Google Scholar 

  56. Campanella NC, Silva EC, Dix G, et al. Mutational profiling of driver tumor suppressor and oncogenic genes in Brazilian malignant pleural mesotheliomas. Pathobiology. 2020;87(3):208–16. https://doi.org/10.1159/000507373.

    Article  CAS  PubMed  Google Scholar 

  57. Muruganandan S, Alfonso H, Franklin P, et al. Comparison of outcomes following a cytological or histological diagnosis of malignant mesothelioma. Br J Cancer. 2017;116(6):703–8. https://doi.org/10.1038/bjc.2017.20.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Bueno R, Reblando J, Glickman J, Jaklitsch MT, Lukanich JM, Sugarbaker DJ. Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma. Ann Thorac Surg. 2004;78(5):1774–6. https://doi.org/10.1016/j.athoracsur.2004.05.007.

    Article  PubMed  Google Scholar 

  59. Flores RM, Pass HI, Seshan VE, et al. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg. 2008;135(3):620-626.e3. https://doi.org/10.1016/j.jtcvs.2007.10.054.

    Article  PubMed  Google Scholar 

  60. Gomez DR, Rimner A, Simone CB, et al. The use of radiation therapy for the treatment of malignant pleural mesothelioma: expert opinion from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation. J Thorac Oncol. 2019;14(7):1172–83. https://doi.org/10.1016/j.jtho.2019.03.030.

    Article  PubMed  Google Scholar 

  61. Henderson DW, Rödelsperger K, Woitowitz HJ, Leigh J. After Helsinki: a multidisciplinary review of the relationship between asbestos exposure and lung cancer, with emphasis on studies published during 1997–2004. Pathology. 2004;36(6):517–50. https://doi.org/10.1080/00313020400010955.

    Article  CAS  PubMed  Google Scholar 

  62. Ngamwong Y, Tangamornsuksan W, Lohitnavy O, et al. Additive synergism between asbestos and smoking in lung cancer risk: a systematic review and meta-analysis. PLoS ONE. 2015;10(8):135798. https://doi.org/10.1371/JOURNAL.PONE.0135798.

    Article  Google Scholar 

  63. Uguen M, Dewitte JD, Marcorelles P, et al. Asbestos-related lung cancers: a retrospective clinical and pathological study. Mol Clin Oncol. 2017;7(1):135–9. https://doi.org/10.3892/MCO.2017.1277.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Dodson RF, O’Sullivan MF, Huang J, Holiday DB, Hammar SP. Asbestos in extrapulmonary sites: omentum and mesentery. Chest. 2000;117(2):486–93. https://doi.org/10.1378/CHEST.117.2.486.

    Article  CAS  PubMed  Google Scholar 

  65. Mukherjee S, De Klerk N, Palmer LJ, Olsen NJ, Pang SC, Musk AW. Chest pain in asbestos-exposed individuals with benign pleural and parenchymal disease. Am J Respir Crit Care Med. 2000;162(5):1807–11. https://doi.org/10.1164/AJRCCM.162.5.9912012.

    Article  CAS  PubMed  Google Scholar 

  66. Copley SJ, Wells AU, Rubens MB, et al. Functional consequences of pleural disease evaluated with chest radiography and CT. Radiology. 2001;220(1):237–43. https://doi.org/10.1148/RADIOLOGY.220.1.R01JL27237.

    Article  CAS  PubMed  Google Scholar 

  67. Cookson WOCM, De Klerk NH, Musk AW. Benign and malignant pleural effusions in former Wittenoom crocidolite millers and miners. Aust N Z J Med. 1985;15(6):731–7.

    CAS  PubMed  Google Scholar 

  68. Mattson SB. Monosymptomatic exudative pleurisy in persons exposed to asbestos dust. Scand J Respir Dis. 1975;56(5):263–72.

    CAS  PubMed  Google Scholar 

  69. Mintzer RA, Cugell DW. The association of asbestos-induced pleural disease and rounded atelectasis. Chest. 1982;81(4):457–60. https://doi.org/10.1378/CHEST.81.4.457.

    Article  CAS  PubMed  Google Scholar 

  70. Jeebun V, Stenton SC. The presentation and natural history of asbestos-induced diffuse pleural thickening. Occup Med (Lond). 2012;62(4):266–8. https://doi.org/10.1093/OCCMED/KQS028.

    Article  CAS  PubMed  Google Scholar 

  71. Norbet C, Joseph A, Rossi SS, Bhalla S, Gutierrez FR. Asbestos-related lung disease: a pictorial review. Curr Probl Diagn Radiol. 2015;44(4):371–82. https://doi.org/10.1067/j.cpradiol.2014.10.002.

    Article  PubMed  Google Scholar 

  72. Roach HD, Davies GJ, Attanoos R, Crane M, Adams H, Phillips S. Asbestos: when the dust settles - an imaging review of asbestos-related disease. Radiographics. 2002. https://doi.org/10.1148/radiographics.22.suppl_1.g02oc10s167.

    Article  PubMed  Google Scholar 

  73. McHugh K, Blaquiere RM. CT features of rounded atelectasis. Am J Roentgenol. 1989;153(2):257–60. https://doi.org/10.2214/ajr.153.2.257.

    Article  CAS  Google Scholar 

  74. Markowitz SB, Levin SM, Miller A, Morabia A. Asbestos, asbestosis, smoking, and lung cancer: new findings from the north American insulator cohort. Am J Respir Crit Care Med. 2013;188(1):90–6. https://doi.org/10.1164/rccm.201302-0257OC.

    Article  PubMed  Google Scholar 

  75. Akira M, Yamamoto S, Yokoyama K, et al. Asbestosis: high-resolution CT-pathologic correlation. Radiology. 1990;176(2):389–94. https://doi.org/10.1148/RADIOLOGY.176.2.2367652.

    Article  CAS  PubMed  Google Scholar 

  76. Guidotti TL, Miller A, Christiani D, et al. Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med. 2012;170(6):691–715. https://doi.org/10.1164/RCCM.200310-1436ST.

    Article  Google Scholar 

  77. Ollier M, Chamoux A, Naughton G, Pereira B, Dutheil F. Chest CT scan screening for lung cancer in asbestos occupational exposure: a systematic review and meta-analysis. Chest. 2014;145(6):1339–46. https://doi.org/10.1378/chest.13-2181.

    Article  PubMed  Google Scholar 

  78. Mensi C, Markowitz SB. Lung cancer screening in asbestos-exposed populations. Int J Environ Res Public Health. 2022;19(5):2688. https://doi.org/10.3390/IJERPH19052688.

    Article  Google Scholar 

  79. Hoshi S, Tamai Y, Tamura A, et al. Silico-asbestosis that responded to steroid therapy. Intern Med. 2006;45(15):917–21. https://doi.org/10.2169/INTERNALMEDICINE.45.1656.

    Article  PubMed  Google Scholar 

  80. Addrizzo-Harris DJ, Harkin TJ, Tchou-Wong KM, et al. Mechanisms of colchicine effect in the treatment of asbestosis and idiopathic pulmonary fibrosis. Lung. 2002;180(2):61–72. https://doi.org/10.1007/S004080000083.

    Article  CAS  PubMed  Google Scholar 

  81. Afaq F, Abidi P, Rahman Q. N-acetyl L-cysteine attenuates oxidant-mediated toxicity induced by chrysotile fibers. Toxicol Lett. 2000;117(1–2):53–60. https://doi.org/10.1016/S0378-4274(00)00236-8.

    Article  CAS  PubMed  Google Scholar 

  82. Alfonso H, Franklin P, Ching S, et al. Effect of N-acetylcysteine supplementation on oxidative stress status and alveolar inflammation in people exposed to asbestos: a double-blind, randomized clinical trial. Respirology. 2015;20(7):1102–7. https://doi.org/10.1111/RESP.12592.

    Article  PubMed  Google Scholar 

  83. • Rytz F, Poellinger A, Berezowska S, Geiser T, Funke-Chambour M. Pirfenidone as a treatment for asbestos-related lung fibrosis? A retrospective case series. Eur Respir J. 2018;52(suppl 62):PA2993. https://doi.org/10.1183/13993003.CONGRESS-2018.PA2993. This study studies some benefit of a Pirfenidone as a possible therapy of asbestos-related disease.

  84. • Remon J, Reguart N, Corral J, Lianes P. Malignant pleural mesothelioma: new hope in the horizon with novel therapeutic strategies. Cancer Treat Rev. 2015;41(1):27–34. https://doi.org/10.1016/J.CTRV.2014.10.007. This paper highlights the novel therapy for the management of asbestos-related lung disease.

Download references

Author information

Authors and Affiliations

  1. Pulmonary and Critical Care Department, Saint Elizabeth Medical Center, Boston, USA

    Wasey Ali Yadullahi Mir, Peter LaCamera & Andrew Moraco

  2. Internal Medicine, John H. Stroger Jr. Hospital of Cook County, Chicago, IL, USA

    Ayusha Poudel

  3. Internal Medicine, Jacobi Medical Center – AECOM, Bronx, NY, USA

    Anurag Adhikari

  4. Internal Medicine, Mount Sinai Hospital, Chicago Medical Center, Chicago, IL, USA

    Dhan Bahadur Shrestha

  5. Pulmonary and Critical Care Department, University of Kentucky College of Medicine, Lexington, USA

    Yubraj Sedhai

Authors
  1. Wasey Ali Yadullahi Mir
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ayusha Poudel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anurag Adhikari
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dhan Bahadur Shrestha
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yubraj Sedhai
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Peter LaCamera
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Andrew Moraco
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wasey Ali Yadullahi Mir.

Ethics declarations

Conflict of Interest

No conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mir, W.A.Y., Poudel, A., Adhikari, A. et al. Asbestos-Related Diseases and Its Impact on Health: An Updated Review Article. Curr Pulmonol Rep 12, 244–255 (2023). https://doi.org/10.1007/s13665-023-00324-x

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13665-023-00324-x

Keywords

Search

Navigation